BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Global Biodefense - ECPv6.18.4//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Global Biodefense
X-ORIGINAL-URL:https://globalbiodefense.com
X-WR-CALDESC:Events for Global Biodefense
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Chicago
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20180311T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20181104T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20190310T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20191103T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20200308T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20201101T070000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20180311T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20181104T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20190310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20191103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20180311T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20181104T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20190310T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20191103T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20200308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20201101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20210314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20211107T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Asia/Tehran
BEGIN:DAYLIGHT
TZOFFSETFROM:+0330
TZOFFSETTO:+0430
TZNAME:+0430
DTSTART:20180321T203000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0430
TZOFFSETTO:+0330
TZNAME:+0330
DTSTART:20180921T193000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0330
TZOFFSETTO:+0430
TZNAME:+0430
DTSTART:20190321T203000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0430
TZOFFSETTO:+0330
TZNAME:+0330
DTSTART:20190921T193000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0330
TZOFFSETTO:+0430
TZNAME:+0430
DTSTART:20200320T203000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0430
TZOFFSETTO:+0330
TZNAME:+0330
DTSTART:20200920T193000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20190331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20191027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20200329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20201025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20211031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Toronto
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20190310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20191103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20190331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20191027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20200329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20201025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20211031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191115
DTEND;VALUE=DATE:20191121
DTSTAMP:20190711T054058Z
CREATED:20190711T050451Z
LAST-MODIFIED:20190711T054058Z
UID:29582-1573776000-1574294399@globalbiodefense.com
SUMMARY:ABSA Annual Biosafety and Biosecurity Conference 2019
DESCRIPTION:The ABSA Annual Biosafety and Biosecurity Conference will be held 15-20 November 2019 in Birmingham\, Alabama. \nProfessional development courses will be November 15-17 and the conference presentations (platform/poster) will be November 18-20. Approximately 700 attendees representing a\nbroad spectrum of biosafety and biosecurity\, pharmaceutical\, biotechnology research\, development\, and clinical organizations are expected to attend. The conference draws national and international attendees from academic\, commercial\, research\, and governmental sectors. \nSessions of interest highlighted by the Global Biodefense staff include: \nBiosafety Critical Task Analysis as a Means to Mitigate Human Failure in a High-Containment Facility – Anna E. Lawton\, BSc\, The Pirbright Institute \nThe Challenge of Arthropod Biocontainment in the Non-model Organism World: Mosquitoes\, Gene Drive\, and Beyond – Zachary Adelman\, PhD\, Texas A&M University \nLarge-scale Decontamination and Decommissioning of a Vintage High-Containment Effluent Decontamination System (EDS)\, Planning Through Execution – Fahim Manzur\, MS\, Plum Island Animal Disease Center \nUtility of the Incident Command System in Laboratory Emergency Management – Kaci VanDalen\, MS\, National Institutes of Health \nEnhancement of Biosafety and Biosecurity in Tanzania Through Surveillance\, Risk Assessment\, and Identification of Select Agents in Bushmeat – Robab Katani\, PhD\, Penn State University \nRisk Assessment and Facility Containment for Research with Gene Drive Arthropods – Sheryl Major\, University of California-San Diego \nSpores or Not Spores\, ‘Tis the Question: Considerations for Biological Verification and Technical Feasibility of Room Fumigations – Daniel Kiimin\, PhD\, Basler & Hofmann AG \nImplementation of WHO Global Action Plan III Containment Certification for US Poliovirus Type 2 Laboratories – Christy Ottendorfer\, PhD\, CDC \nBiosafety and Biosecurity Measures in the Epidemiological Surveillance of Rabies Virus and Other Lyssaviruses in Mexico – Luis Alberto Ochoa Carrera\, MS\, Institute for Epidemiological Diagnosis and Reference (InDRE) \nMicrobial Aerosols in the Modern Microbiology Laboratory – Allan Bennett\, MSc\, Public Health England\, Porton Down \nPrion-like Proteins: Implementation of IBC Oversight – Susan Vleck\, PhD\, RBP(ABSA)\, Stanford University \n// \nPlease visit the ABSA Annual Biosafety and Biosecurity Conference website for more information.
URL:https://globalbiodefense.com/event/absa-annual-biosafety-and-biosecurity-conference-2019/
LOCATION:Birmingham-Jefferson Convention Complex\, 2100 Richard Arrington Jr. Blvd N\, Birmingham\, AL\, 35203\, United States
CATEGORIES:Conference
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20191115T080000
DTEND;TZID=America/Chicago:20191115T150000
DTSTAMP:20190711T053626Z
CREATED:20190711T042959Z
LAST-MODIFIED:20190711T053626Z
UID:29577-1573804800-1573830000@globalbiodefense.com
SUMMARY:BSL-3 Operations and Management Course
DESCRIPTION:A professional development course reviewing the important aspects of Biosafety Level 3 (BSL-3) facility and laboratory operations will be offered on 15 November 2019 as part of the ABSA’s  62nd Annual Biosafety and Biosecurity Conference. \nThe course will cover approval and training of BSL-3 workers; maintenance support; occupational health issues; managing waste; maintenance of the BSL-3 HVAC and physical facility; periodic checks on the facility’s systems; and emergencies of different types. \nDaily operations in a BSL-3 will be discussed\, including: \n\nUnderstanding when it is safe to enter and when you need to evacuate\nWhat to do when the ventilation fails\nPractical aspects of entry and exit procedures\nPractical tips on selection and use of personal protective equipment (PPE)\nSafety considerations within the experimental SOPs\nWaste handling; facility cleaning\nHow to have equipment repaired or serviced\n\nPlease visit the ABSA website for more information on this course offering.
URL:https://globalbiodefense.com/event/bsl-3-operations-and-management-course/
LOCATION:Birmingham-Jefferson Convention Complex\, 2100 Richard Arrington Jr. Blvd N\, Birmingham\, AL\, 35203\, United States
CATEGORIES:Conference
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191118
DTEND;VALUE=DATE:20191122
DTSTAMP:20190817T235230Z
CREATED:20190808T045914Z
LAST-MODIFIED:20190817T235230Z
UID:29811-1574035200-1574380799@globalbiodefense.com
SUMMARY:CBD S&T Conference 2019 - Chemical and Biological Defense
DESCRIPTION:The Defense Threat Reduction Agency (DTRA) will host the 2019 Chemical and Biological Defense Science & Technology (CBD S&T) Conference at the Duke Energy Convention Center\, in Cincinnati\, Ohio\, 18-21 Nov\, 2019. \n\n\n\nCollaborate with more than 1\,500 scientists\, program managers and leaders from across the globe who are committed to making the world safer by confronting chemical and biological defense challenges. Attendees will also have the opportunity to network with DTRA science and technology managers as well as other members of DTRA’s Chemical and Biological Defense team. \n\n\n\nHighlighted session topics include: \n\n\n\n\nUse Prognostic and Predictive Host Response Biomarkers to Inform Medical Treatment and/or Therapies\nSynthetic Biology to Enhance Detection and Diagnostic Capabilities\nGenotypic to Phenotypic Analysis Tools to Characterize Novel Emerging Threats\nAnimal Models and Predictive Systems to Determine Optimal Countermeasure Efficacy\nToxin Assessment for Development of Medical Countermeasures\nToxicological Assessments of Aerosol Exposures to Biotoxins\nNew Methods For Modeling Emerging Threat Agents\, Dissemination Devices and CWMD Scenario Development\nOrganoids and Organs-on-a-Chip Revolutionizing Drug Development\nDevelopment of Next Gen Antibody-Based Anti-Infective Therapeutics\nAdvances in Chemical Plume Characterization Technologies in Large-Scale Releases\nIdentification Therapeutic Combinations That Avoid Interference of Vaccine-Induced Immunity\nHost Targeted Therapies: Pathogen Entry\, Replication\, Egress; Common Pathways of End State Disease; Host Immune Modifiers\nArtificial Intelligence for Early Drug Discovery\nFeasibility and Utility of Toxidrome-Based Medical Countermeasures\nEmerging hazard prediction techniques (e.g. graphical processing unit applications\, neural networks\, machine learning)\n\n\n\n\nPlease visit the CBD S&T Conference website to register today.
URL:https://globalbiodefense.com/event/cbd-st-conference-2019-chemical-and-biological-defense-science-technology/
LOCATION:Duke Energy Convention Center\, 525 Elm St.\, Cincinnati\, Ohio\, 45202\, United States
CATEGORIES:Conference
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2019/08/DTRA-CBDST-GBD-CBRNE-Digital-Ad_700x400.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191119
DTEND;VALUE=DATE:20191122
DTSTAMP:20190822T193456Z
CREATED:20190822T193456Z
LAST-MODIFIED:20190822T193456Z
UID:30103-1574121600-1574380799@globalbiodefense.com
SUMMARY:EPA International Decontamination Research and Development Conference 2019
DESCRIPTION:The EPA’s National Homeland Security Research Center (NHSRC) will host the 2019 International Decontamination Research and Development Conference 19-21 November 2019 in Norfolk\, Virginia. \nDecontamination is one of the critical challenges that the United States and EPA would face in recovering from a major chemical\, biological\, or radiological (CBR) incident. The conference is designed to facilitate presentation\, discussion\, and further collaboration on research and development focused on an all-hazards approach to cleaning up contaminated buildings (both interior and exterior)\, infrastructure\, and other areas/materials. The conference continues to focus strongly on matters involving CBR threat agents\, but also includes all hazard elements. \nTopics for this conference include: \n\nNew chemical\, biological\, and radiological (CBR) detection and decontamination research data or field activities and large scale demonstrations related to the detection and decontamination of biological (including agricultural threat agents and biotoxins)\, chemical\, and radiological threat agents in indoor (in facilities) or outdoor areas/materials;\nCross-cutting topics related to restoration\, including: clean-up levels/risk assessment\, exposure assessment\, sampling/analysis of threat agents\, fate/transport/containment\, material compatibility with decontamination processes\, tool and guidance development\, waste management of threat agent-contaminated materials\, water/wastewater decontamination\, and systems approach to response and regulatory issues;\nRegional\, state\, and local initiatives highlighting local priorities\, challenges\, and science and technology developments related to response and recovery efforts from intentional or accidental environmental incidents; and\nCoastal Operational Resiliency (AnCOR) project: presentations and preliminary findings of the EPA/DHS/USCG collaborative project focusing on the post-biological incident consequence management (sampling\, decontamination\, waste management\, etc.) of urban and maritime structures\, assets\, and surfaces.\nIllicit Drug Remediation Efforts: Opioid Epidemic Efforts\nBig Data\, Artificial Intelligence\, Information Sharing\, Mapping\, & System Integration in Disaster Response\nCase Studies/Applied Research: Engaging Federal\, State\, Local Responders\, and Industry\nCase Studies/Applied Research: How Does Bench Scale Correlate to Real Scenarios?\n\nClick here to register for the 2019 EPA International Decontamination Research and Development Conference.
URL:https://globalbiodefense.com/event/epa-international-decontamination-research-and-development-conference-2019/
LOCATION:Sheraton Norfolk Waterside Hotel\, 777 Waterside Drive\, Norfolk\, VA\, 23510\, United States
CATEGORIES:Conference
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191120
DTEND;VALUE=DATE:20191125
DTSTAMP:20190927T174635Z
CREATED:20190907T232320Z
LAST-MODIFIED:20190927T174635Z
UID:30286-1574208000-1574639999@globalbiodefense.com
SUMMARY:ASTMH 2019 - American Society of Tropical Medicine and Hygiene
DESCRIPTION:The American Society of Tropical Medicine and Hygiene will host the 2019 ASTMH Annual Meeting on 20-24 November 2019 in National Harbor\, Maryland. \nThis 5-day five-day educational conference that includes four pre-meeting courses draws approximately 4\,800 tropical medicine and global health professionals representing academia\, government\, non-profits\, philanthropy\, NGOs\, industry\, military and private practice. \nThe meeting is designed for researchers\, professors\, government and public health officials\, military personnel\, travel clinic physicians\, practicing physicians in tropical medicine\, students and all health care providers working in the fields of tropical medicine\, hygiene and global health. \n \nThis year’s pre-meeting courses include: \n\nTropical Diseases Encountered in Non-Travel Clinics (Clinical Group)\nImaging Parasites from Single Molecules to Entire Organsims (Parasitology)\nArboviromics: How ‘omics’ Technologies are Advancing Arbovirus Research\nand Control (Arbovirology)\nField Applications for Stopping Infectious Disease Threats at International\nPoints of Entry (Global Health)\n\nPlease visit the ASTMH Annual Meeting website for more information: http://bit.ly/ASTMH2019TropMed
URL:https://globalbiodefense.com/event/astmh-annual-meeting-2019/
LOCATION:Gaylord National Resort and Convention Center\, 201 Waterfront Street\, National Harbor\, MD\, 20745\, United States
CATEGORIES:Conference,Continuing Education
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191121T090000
DTEND;TZID=America/New_York:20191121T103000
DTSTAMP:20191115T041744Z
CREATED:20191115T041446Z
LAST-MODIFIED:20191115T041744Z
UID:33870-1574326800-1574332200@globalbiodefense.com
SUMMARY:All of Us: How Public Health Can Learn From and Inform the Precision Medicine
DESCRIPTION:The Office of Genomics and Precision Public Health\, Office of Science\, Centers for Disease Control and Prevention will host a Webinar on 21 Nov 2019 on the All of Us research program. \nThe National Institute of Health (NIH)-led All of Us research program aims to enroll over one million people in the U.S. in a research cohort to improve understanding of how individual differences in lifestyle\, socioeconomics\, environment\, and biology affect health outcomes. \nRecruiting a diverse research cohort is key to ensuring that findings will be broadly applicable\, and All of Us strives to include participants from groups historically underrepresented in biomedical research. Join us to learn more about the All of Us research program\, better understand how the approaches used to recruit All of Us participants can inform future public health efforts to address diversity\, and share your expertise in increasing diverse participation in your own public health work. \nFree Online Webinar\nRegistration is required. Please register.\nView the Webinar via Skype\nPhone: (855) 644-0229\, Conference ID: 4390261
URL:https://globalbiodefense.com/event/all-of-us-how-public-health-can-learn-from-and-inform-the-precision-medicine/
LOCATION:Centers for Disease Control and Prevention\, 1600 Clifton Road\, Atlanta\, GA\, 30329\, United States
CATEGORIES:Conference,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191121T140000
DTEND;TZID=America/New_York:20191121T153000
DTSTAMP:20190927T181033Z
CREATED:20190927T181033Z
LAST-MODIFIED:20190927T181033Z
UID:30701-1574344800-1574350200@globalbiodefense.com
SUMMARY:Ebola and Beyond: Legal Preparedness for Outbreaks
DESCRIPTION:A webinar on the Legal Preparedness for Outbreaks will be held 21 Nov 2019 at 2:00pm Eastern. \nThe discussion will examine challenges public health professionals and responders are facing during the Ebola response\, as well as current legal provisions and concepts and how to apply them to future infectious disease emergency response planning. In addition\, as studies show vulnerable populations are the most significantly impacted when disasters strike\, this webinar will highlight protection of vulnerable populations for the next communicable disease outbreak of public health concern. \nThe webinar is the 3rd in a 4-part series on Legal Preparedness for Public Health Emergencies hosted under a collaborative effort by the National Governors Association\, U.S. Centers for Disease Control and Prevention and the American Bar Association. \nRegister here.
URL:https://globalbiodefense.com/event/ebola-and-beyond-legal-preparedness-for-outbreaks/
LOCATION:Webinar
CATEGORIES:Conference,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191125
DTEND;VALUE=DATE:20191130
DTSTAMP:20191202T065934Z
CREATED:20190902T055607Z
LAST-MODIFIED:20191202T065934Z
UID:34816-1574640000-1575071999@globalbiodefense.com
SUMMARY:International Workshop on Medical Defence in CBRN Incidents
DESCRIPTION:The Baqiyatallah University of Medical Sciences has arranged an International Workshop on Medical Defence in CBRN from 25 to 29 November 2019\, as a part of the two-year program of the ICMM Pan Asia Pacific Regional Working Group for international participants. This scientific program will be presented within 5 days in Tehran\, the capital city of Iran. \nThe main topics of the scientific program include:\n1. Advances in CBRN Victim’s Management\n2. General Considerations of Medical Management of CBRN Casualties\n3. Physical Protection Against CBRN Agents (Individual)\n4. Principles of Decontamination After CBRN Incidents\n5. Triage of CBRN Casualties / Medical Evacuation\n6. Diagnosis and Treatment of CBRN Exposure\n7. Field Practice (I) (Pre-Hospital)\n8. Field Practice (II) (In the Hospital Emergency) \nThe workshop will be held in English and on-site translators for communications. \nThe ICMM will support young researchers by partially funding their participation and accommodation costs needed for attending ICMM scientific congresses and meetings. In this regard\, in order to strengthen and enforce this resolution\, the Islamic Republic of Iran intends to offer young eligible researchers (under the age of 40) a 50% discount in this international workshop.
URL:https://globalbiodefense.com/event/international-workshop-on-medical-defence-in-cbrn-incidents/
CATEGORIES:Conference
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191203
DTEND;VALUE=DATE:20191207
DTSTAMP:20190812T160200Z
CREATED:20190812T160200Z
LAST-MODIFIED:20190812T160200Z
UID:29976-1575331200-1575676799@globalbiodefense.com
SUMMARY:Epidemics7 - International Conference on Infectious Disease Dynamics
DESCRIPTION:Epidemics7 – International Conference on Infectious Disease Dynamics Conference will bring together leaders from industry and academia to exchange and share their experiences\, present research results\, explore collaborations and to spark new ideas\, with the aim of developing new projects and exploiting new technology. \nTopics areas of interest include: \n\nDynamics of infectious diseases of humans\nDynamics of infectious diseases of animals\nWithin-host dynamics and immuno-epidemiology\nEcology of infectious diseases\nEvolution and phylodynamics in infectious diseases\nDynamics and consequences of antimicrobial resistance\nGlobal\, economic and policy aspects of control and prevention\nStatistical methods for infectious disease data\nSocial\, spatial and network aspects of interaction\nProblems related to the “end game” of eradication\nZoonoses and other cross-species events\nVector-borne diseases\nHost behaviour and infectious diseases\nMulti-host and multi-pathogen/parasite systems\nProblems in vaccine-preventable infections & vaccination strategy\nProblems in neglected tropical macroparasitic diseases\n\nAbstracts will be considered for poster presentations until September 20\, 2019. \nPlease visit Elsevier’s Epidemics7 event website for more information and registration.
URL:https://globalbiodefense.com/event/epidemics7-international-conference-on-infectious-disease-dynamics/
LOCATION:Embassy Suites by Hilton Charlston Airport\, 5055 International Boulevard\, North Charleston\, SC\, 29418\, United States
CATEGORIES:Conference
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191209T093000
DTEND;TZID=America/New_York:20191209T170000
DTSTAMP:20191201T160907Z
CREATED:20191201T160848Z
LAST-MODIFIED:20191201T160907Z
UID:34803-1575883800-1575910800@globalbiodefense.com
SUMMARY:MADNano: Maryland DNA Nanotechnology Conference
DESCRIPTION:MADNano is a recurring local conference for the DNA Nanotechnology field in the mid-Atlantic region.  Its purpose is to provide opportunities to collaborate and to stimulate intelligent discussions in the region. Scientists\, researchers\, and students are invited to a day-long symposium that comprises short talks on recent advances in DNA nanotechnology\, poster sessions\, and networking opportunities. Contributors are encouraged to frame their work in the context of the needs of the field as it begins the uphill trek to industrial implementation. \nHighlighted agenda topics include: \n\nTowards a synthetic genome for materials: Challenges beyond the test tube\nSelf-Assembled 3D DNA Crystals as Vehicles for Drug Delivery\nHigh Throughput Evolution of Near-Infrared Serotonin Nanosensors\nProgress Towards Development of Self-Assembled Three-Dimensional Electronic Systems with DNA Hydrogel\nBarriers to Implementation of Nucleic Acid Nanotechnology\nRNA Nanoparticles as Triple-Modality Immunotherapy\nA novel computer-aided design (CAD) system for DNA nanotechnology\nDNA origami as a high-density fluorophore template for improved molecular photonic wires\nIn vivo Biodistribution of an Anti-ICAM-Functionalized Drug Delivery Nanocarrier made of DNA (3DNA)\nControlling Carbon Nanotubes by DNA: from Separation to Integration\n\nThe National Institute of Standards and Technology (NIST)’s Physical Measurement Laboratory (PML) is hosting the event. There is no registration fee to attend this conference. Please register by December 2\, 2019 to ensure your spot at this event.
URL:https://globalbiodefense.com/event/madnano-maryland-dna-nanotechnology-conference/
LOCATION:National Institutes of Standards and Technology (NIST)\, 100 Bureau Drive\, Gaithersburg\, MD\, 20899\, United States
CATEGORIES:Conference
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191211
DTEND;VALUE=DATE:20191212
DTSTAMP:20191117T030306Z
CREATED:20191117T023811Z
LAST-MODIFIED:20191117T030306Z
UID:34095-1576022400-1576108799@globalbiodefense.com
SUMMARY:DARPA DIGET Proposers Day - Detect It with Gene Editing Technologies
DESCRIPTION:The Biological Technologies Office (BTO) of the Defense Advanced Research Projects Agency (DARPA) is hosting a Proposers Day for the potential proposer community in support of a planned Broad Agency Announcement (BAA) for the DIGET (Detect It with Gene Editing Technologies) Program. \nThe Proposers Day will be held on December 11\, 2019 from 8:00 AM to 6:00 PM ET at the Hyatt Regency in Atlanta\, GA. \nThe DoD requires timely and comprehensive threat detection to support overall readiness\, counter the spread of disease\, and promote stabilization missions. The DIGET program aims to deliver this capability\, leveraging advances in gene editing technologies to develop low-cost\, high-trust\, rapidly reconfigurable\, and fieldable diagnostic (Dx) and biosurveillance (BSV) technologies to enable detection of any threat\, anytime\, anywhere. \nThe Proposers Day goals include:\n1. Introduce the DIGET program vision and goals;\n2. Explain the mechanics of a DARPA program in general and the objectives and milestones\nof this program in particular; and\n3. Encourage and promote teaming arrangements among organizations that have the relevant\nexpertise\, research facilities\, and capabilities for executing research and development\nresponsive to the DIGET program goals. \nThe Proposers Day will include brief overview presentations by government personnel as well as\nan information session to respond to questions from participants. Potential performers can\nhighlight their technical capabilities through “lightning” talks such that teaming relationships can\nbe developed. Lightning talk presentations will be made accessible to the proposer community on\nthe DIGET program website after presentation at the Proposers Day. It is expected that DIGET\nwill require strong teaming efforts to successfully innovate and integrate critical technologies\nnecessary to meet the metrics of the program. Private sidebar meetings with the DARPA\ngovernment team and potential proposer teams can be scheduled beforehand on the registration\nwebsite. \nAttendance at this event is not a requirement for submission of a proposal or selection for funding.\nInformation relayed during the Proposers Day will be made available on the BTO section of the\nDARPA Opportunities page: http://www.darpa.mil/work-with-us/opportunities. \nInterested attendees are invited to present a brief one-slide PowerPoint summary of their interests\, capabilities\, and teaming goals. Speakers will be allowed 3 minutes for discussion during a\n“lightning” presentation session at Proposers Day. Presentations consisting of multiple slides will\nnot be granted a time slot. Requests for lightning talks and sidebar meetings will be accepted on\na first-come basis. All presentations must be emailed to DARPA-SN-20-12@darpa.mil\nno later than 12:00 PM ET on December 2\, 2019. Specific content\, communications\, networking\,\nand team formation are the sole responsibility of the participants. \nRegistration Information:\nPLEASE NOTE: Registration closes on December 2\, 2019 at 12:00 PM ET. \nRegistration is limited by the venue capacity\, and early registration is strongly recommended. The\nregistration cutoff date is December 2\, 2019 at 12:00 PM EST\, or once attendance capacity is met\,\nwhichever comes first. There will be no on-site registration. \nParticipants must register in advance through the registration website. There will be a $25\nregistration fee for the Proposers Day. Early registration is strongly recommended. Due to space\nlimitations\, attendance for the Proposers Day will be limited to the first 150 registrants. Interested\nparties are encouraged to coordinate attendance internally within their organizations prior to\nregistration. Attendance is limited to no more than two representatives per division/department.\nIndividuals that are unable to register because the deadline has occurred or capacity has been\nreached will be added to a waitlist. If slots remain open after registration closes or become\navailable due to cancellations\, the slots will be filled on a first-come\, first-serve basis from the\nwaitlist. An online registration form and various other meeting details can be found at the\nregistration website: https://events.sa-meetings.com/DIGETProposersDay. \nPotential proposing teams are not required to attend Proposers Day\, although participation is\nstrongly encouraged. \n\n\n\n\nContact Information\nPlease direct all questions to DARPA-SN-20-12@darpa.mil and refer to the DIGET Proposers Day (DARPA-SN-20-12) in all correspondence. \nGlobal Biodefense is a news publication and not directly responsible for this event. Information is subject to change. Please contact the event organizers for the most up-to-date information.
URL:https://globalbiodefense.com/event/darpa-diget-proposers-day/
LOCATION:Hyatt Regency Atlanta\, 265 Peachtree street NE\, Atlanta\, 30303\, United States
CATEGORIES:Conference,Industry Day
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200114
DTEND;VALUE=DATE:20200116
DTSTAMP:20200115T041521Z
CREATED:20191201T155453Z
LAST-MODIFIED:20200115T041521Z
UID:34798-1578960000-1579132799@globalbiodefense.com
SUMMARY:Ultraviolet Disinfection Technologies & Healthcare Associated Infections
DESCRIPTION:The National Institute of Standards and Technology (NIST) is co-hosting a 2-day meeting with the International Ultra Violet Association (IUVA) focused on examining measurement\, standards\, technology and data research needs to promote innovation in the effective use and implementation of ultraviolet-C (UVC) technology in healthcare settings for the reduction and prevention of healthcare associated infections (HAIs). \nThis unique event provides the community with an opportunity to learn about the current science in HAI prevention with UVC and to discuss standard needs in both the physical and biological performance areas for UVC disinfection devices. \nHAIs are recognized as an important public health and patient safety issue. UVC devices are shown to reduce the incidence of many HAIs\, but the adoption of the technology by the healthcare industry has been sparse. There is a lack of performance standards to help healthcare managers make informed\, credible investment decisions. Measurements and standards in the light and biological sciences are needed to accelerate the adoption of UVC technology in the healthcare market. \nThrough two days of targeted programming\, attendees will learn about the latest developments in UVC technology\, engineering and operations\, and regulatory issues related to disinfection. Current measurements\, standards and data supporting UVC disinfection will be discussed in the context of innovation and implementation. Input from the event will be used by the community for the development of proposed performance standards for UVC disinfection devices. \nProgramming will include plenary presentations from invited keynote subject matter experts and round table engagements with representatives from industry\, academia and federal agencies. There will be optional campus lab tours where attendees can view up-close NIST’s metrology R&D in the UV and biological sciences\, including UV calibrations and biological measurements. \nRegistration contact: Karen M. Startsman\, karen.startsman@nist.gov (301) 975-6602 \nEditor’s note (1 Dec 2019): Registration is expected to open shortly.  Please check this website for the latest information updates. Once registration is open\, it is expected to remain open until Tuesday\, January 7\, 2020.
URL:https://globalbiodefense.com/event/ultraviolet-disinfection-technologies-healthcare-associated-infections/
LOCATION:National Institutes of Standards and Technology (NIST)\, 100 Bureau Drive\, Gaithersburg\, MD\, 20899\, United States
CATEGORIES:Conference
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2019/12/ultra-violet-disinfection-hai-healthcare-associated-infections.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200123
DTEND;VALUE=DATE:20200125
DTSTAMP:20200105T182855Z
CREATED:20191205T175457Z
LAST-MODIFIED:20200105T182855Z
UID:36104-1579737600-1579910399@globalbiodefense.com
SUMMARY:National Science Advisory Board for Biosecurity (NSABB) Meeting
DESCRIPTION:The National Science Advisory Board for Biosecurity (NSABB) will convene 23-24 January 2020 in Bethesda\, Md. \nThe meeting will be open to the public\, with attendance limited to space available. The meeting will also be videocast. \nJanuary 23: 12:30 PM – 5 PM Eastern\nJanuary 24: 9 AM – 2:30 PM Eastern \nThe purpose of this meeting is to discuss considerations regarding security and public transparency when sharing information about research involving enhanced potential pandemic pathogens; as well as other business of the Board. \nIf you plan to attend the meeting in person please pre-register HERE.\nIndividuals in attendance may also register onsite on the day of the meeting.\nDraft Agenda will be posted when available. \nVideocasts: \n\nDay 1 – Link will be available on January 23\, 2020\nDay 2 – Link will be available on January 24\, 2020\n\nPlease visit the website for more information: http://bit.ly/NSABB-Meetings \nCurrent Voting Board Members\nMargie D. Lee\, DVM\, PhD*\nProfessor and Head\, Department of Biomedical Sciences and Pathobiology\nVirginia-Maryland College of Veterinary Medicine\nVirginia Tech \nStephen S. Morse\, PhD*\nDirector\, Infectious Disease Epidemiology Certificate Program\nProfessor of Epidemiology\nMailman School of Public Health\nColumbia University \nJean L. Patterson\, PhD\nProfessor\, Virology and Immunology Chair\, BSL-4 Task Force\nTexas Biomedical Research Institute \nRozanne M. Sandri-Goldin\, PhD\nProfessor and Chair\, Department of Microbiology and\nMolecular Genetics\nUniversity of California Irvine School of Medicine \nKenneth Bernard\, MD\nRADM\, U.S. Public Health Service (Ret.)\nFormer Special Assistant to the President for Biodefense\, Homeland Security Council\, White House\nFormer Special Adviser for Health and Security on the National Security Council \nCraig E. Cameron\, PhD\nJeffrey Houpt Distinguished Investigator\nChair\, Department of Microbiology and Immunology\nUniversity of North Carolina Chapel Hill School of Medicine \nMark Denison\, MD\nProfessor and Chair of Pediatrics\nAssociate Professor of Microbiology and Immunology\nVanderbilt University School of Medicine \nJohn D. Grabenstein\, RPh\, PhD\nSenior Medical Director\, Adult Vaccines\nMerck Vaccine Division\nMerck & Co.\, Inc. \nMarie-Louise Hammarskjöld\, MD\, PhD\nCharles H. Ross Jr. Professor and Professor of Microbiology\, Immunology\, and Cancer Biology\nAssociate Director\, Myles H. Thaler Center\nUniversity of Virginia School of Medicine \nJames W. LeDuc\, PhD\nDirector\, Galveston National Laboratory\nProfessor\, Department of Microbiology and Immunology\nUniversity of Texas Medical Branch
URL:https://globalbiodefense.com/event/national-science-advisory-board-for-biosecurity-nsabb-meeting/
LOCATION:Hyatt Regency Bethesda\, One Bethesda Metro Center\, Bethesda\, MD\, 20814\, United States
CATEGORIES:Conference,Government Hosted,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200128
DTEND;VALUE=DATE:20200131
DTSTAMP:20200117T055633Z
CREATED:20190809T194705Z
LAST-MODIFIED:20200117T055633Z
UID:29873-1580169600-1580428799@globalbiodefense.com
SUMMARY:2020 ASM Biothreats
DESCRIPTION:The leading annual conference on biodefense\, biosecurity and biological threats\, ASM Biothreats\, will be held January 28–30\, 2020 in Arlington\, Virginia. \nHosted by the American Society for Microbiology\, this one-of-a-kind meeting draws stakeholders from government\, academia and industry for an important exchange of knowledge and ideas that will shape the future of high consequence pathogen research. \nASM Biothreats offers a unique program that explores the latest developments and emerging technologies in the industry. \nA few highlights in this year’s outstanding agenda include: \n\nSmallpox: Development and Use of the Panoply of Countermeasures in the Armamentarium\nBiomarkers for Biothreats: New Opportunities for Discovery and Verification\nResearch and Innovation to Inform Management of High Consequence Infectious Pathogens\nAggressive Measures to Develop Assays and Animal Models to Combat ZIKV Infection \nNew Developments in Antimicrobials\nFrom Surveillance to Bedside: Tools for the Next Outbreak\nBasic Vector Biology Research to Combat Vector-borne Diseases\nImmune Correlates of Protection for Vaccines against Biothreat Viruses\nEvolution of Biothreat Viruses\nIntracellular Bacteria – Pathogenesis and Countermeasures\nInnovations in Biothreat Detection\nInternational Collaboration without Complications and Confusion\nVaccine Development Efforts Against Bacterial Biothreats\n\nPlease visit the ASM Biothreats 2020 website to register. \nGlobal Biodefense is an official media partner of ASM Biothreats.
URL:https://globalbiodefense.com/event/2020-asm-biothreats/
LOCATION:Hyatt Regency Crystal City\, 2799 Jefferson Davis Highway\, Arlington\, VA\, 22202\, United States
CATEGORIES:Conference
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2019/08/asm-biothreats-2020-lg-bnr.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200203T083000
DTEND;TZID=America/New_York:20200203T170000
DTSTAMP:20200115T031436Z
CREATED:20191115T030617Z
LAST-MODIFIED:20200115T031436Z
UID:37038-1580718600-1580749200@globalbiodefense.com
SUMMARY:Advancing EUA IVD Products Toward Full Marketing Status
DESCRIPTION:The Medical Device Innovation Consortium (MDIC) will host a workshop on 3 Feb 2020 to explore key considerations for using real world data to help support in vitro diagnostic (IVD) products available under FDA’s emergency use authorization (EUA) to advance to full marketing status. \nA roadmap for diagnostic evaluations during emergencies would help enable stakeholders to have templates to use to expedite evaluation of laboratory-based tests and point of care technologies. By convening a broad range of government and industry stakeholders\, the goal of the workshop is: \nTo identify challenges and next steps to the use of RWD/RWE to help support the advancement of EUA IVD products to full marketing status. \nThe projected outcomes of the workshop include: \n\nIdentify test case(s) of interest to stakeholders\nDiscussion to inform development of a roadmap for diagnostic evaluations during emergencies\, to include what elements to collect (and how)\nIdentify potential projects or next steps for the test case(s) of interest\n\nKeynote Speakers: \n\nLuciana Borio\, MD; Vice President\, Technical Staff | In-Q-Tel\nNira Pollock\, MD\, PhD; Assoc Medical Director of Infectious Diseases Diagnostic Laboratory at Boston Children’s Hospital\, faculty member of the Division of Infectious Diseases at Beth Israel Deaconess Medical Center\, Boston\, MA.\n\nFDA Speakers: \n\nRADM Denise Hinton\, FDA Chief Scientist\nTimothy Stenzel\, MD\, PhD\, Director\, OHT7: Office of In Vitro Diagnostics and Radiological Health | CDRH\nUwe Scherf\, M.Sc.\, PhD\, Director\, Division of Microbiology Devices\, OHT7: Office of In Vitro Diagnostics and Radiological Health | CDRH
URL:https://globalbiodefense.com/event/advancing-eua-ivd-products-toward-full-marketing-status/
LOCATION:FDA White Oak Campus\, 10903 New Hampshire Ave\, Silver Spring\, MD\, 20993\, United States
CATEGORIES:Conference,Workshop
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200206T173000
DTEND;TZID=America/New_York:20200206T190000
DTSTAMP:20200206T190217Z
CREATED:20200203T163455Z
LAST-MODIFIED:20200206T190217Z
UID:38437-1581010200-1581015600@globalbiodefense.com
SUMMARY:Yale Forum on Outbreak of Novel Coronavirus
DESCRIPTION:In response to news and concerns about the respiratory illness outbreak caused by a novel coronavirus initially identified in China\, the Yale Institute for Global Health\, Yale School of Public Health and the Global Health Justice Partnership will hold a discussion and question and answer session on Thursday\, February 6\, 2020. Panelists will address the epidemiology of the disease\, its impact on public health\, human rights issues and how information on such outbreaks is communicated to the public.\n\nModerator \nSaad Omer\, Director\, Yale Institute for Global Health; Professor of Medicine (Infectious Diseases)\, Yale School of Medicine; Susan Dwight Bliss Professor of Epidemiology of Microbial Diseases\, Yale School of Public Health \nPanelists \nEllen Foxman\, Assistant Professor of Laboratory Medicine and Immunobiology\, Yale School of Medicine \nGregg Gonsalves\, Assistant Professor of Epidemiology; Associate (Adjunct) Professor of Law\, Yale Law School; Co-Director\, Global Health Justice Partnership \nNathan Grubaugh\, Assistant Professor of Epidemiology (Microbial Diseases)\, Yale School of Public Health \nLisa Sanders\, Associate Professor of Medicine (General Medicine)\, Yale School of Medicine; Emmy-award winning television producer\, author of The New York Times column Diagnosis \nDavid Vlahov\, Professor\, PhD Program Director\, Yale School of Nursing \nLive Stream Link \nhttps://yale.hosted.panopto.com/Panopto/Pages/Viewer.aspx?id=50702300-d8eb-4398-9d9e-ab530102bbbe
URL:https://globalbiodefense.com/event/yale-forum-on-outbreak-of-novel-coronavirus/
LOCATION:Winslow Auditorium\, 60 College Street\, LEPH 109\, New Haven\, CT\, 06510\, United States
CATEGORIES:Conference,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200210T133000
DTEND;TZID=America/New_York:20200210T153000
DTSTAMP:20200203T162053Z
CREATED:20200203T161203Z
LAST-MODIFIED:20200203T162053Z
UID:38397-1581341400-1581348600@globalbiodefense.com
SUMMARY:Containing the Coronavirus: Challenges to Thwarting the Outbreak
DESCRIPTION:Hudson Institute and the Bipartisan Commission on Biodefense will host a panel discussion on the ongoing coronavirus outbreak and how the United States can respond to the growing outbreak effectively. \nConfirmed infections of the coronavirus in China have exceeded that of the 2002-2003 SARS epidemic\, with thousands more suspected cases. As the number of cases increases\, concerns are mounting that the global community may not be adequately prepared to prevent the disease from significantly spreading. \nThe virus has already spread to more than 20 countries\, including the United States\, with at least six confirmed cases and more than 100 suspected across 36 states. The Center for Disease Control (CDC) is screening passengers arriving from China at several airports\, but much remains unknown about transmission and symptoms\, and a CDC-developed diagnostic test has yet to be distributed across the country. \nPanel participants will offer their perspectives on the role of the federal government in managing the crisis\, the lack of transparency by the Communist Chinese Government\, implications for U.S national security\, and how the country can better prepare for when the next pandemic strikes. \nThe event will feature U.S. Senator Joe Lieberman\, co-chair of the Bipartisan Commission on Biodefense\, scholars from Hudson Institute\, and other subject matter experts. \nNOTE: This event is open to the press. All members of the media should RSVP to press@hudson.org.
URL:https://globalbiodefense.com/event/containing-the-coronavirus-challenges-to-thwarting-the-outbreak/
LOCATION:Hudson Institute\, 1201 Pennsylvania Avenue Northwest\, #400\, Washington\, DC\, 20004\, United States
CATEGORIES:Conference,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20200210T150000
DTEND;TZID=America/Los_Angeles:20200210T170000
DTSTAMP:20200203T162654Z
CREATED:20200203T162525Z
LAST-MODIFIED:20200203T162654Z
UID:38426-1581346800-1581354000@globalbiodefense.com
SUMMARY:The Novel Coronavirus: What Do We Know and What's Next?
DESCRIPTION:The UCLA Fielding School of Public Health and the UCLA Center for Chinese Studies present The Novel Coronavirus: What Do We Know and What’s Next?\, a symposium and reception. The novel coronavirus (2019-nCoV) was first reported in Wuhan\, China in December 2019. On January 30\, 2020\, the WHO declared the outbreak a public health emergency of international concern. To address what we know and what’s next\, join Ron Brookmeyer\, dean of the UCLA Fielding School of Public Health\, and Michael Berry\, director of the UCLA Center for Chinese Studies\, in conversation with: \n\nRoger Detels\, professor\, UCLA Fielding School of Public Health\nAnne Rimoin\, professor\, UCLA Fielding School of Public Health\nAlex Wang\, professor\, UCLA School of Law\nOtto Yang\, professor\, Geffen School of Medicine at UCLA\nZuo-Feng Zhang\, professor\, UCLA Fielding School of Public Health\n\nFor more information\, including how to join the symposium via livestream\, please visit \nhttps://ph.ucla.edu/events/novel-coronavirus-what-do-we-know-and-whats-next
URL:https://globalbiodefense.com/event/the-novel-coronavirus-what-do-we-know-and-whats-next/
LOCATION:Neuroscience Research Building (NRB)\, 635 Charles E Young Drive South\, Los Angeles\, CA\, 90095\, United States
CATEGORIES:Conference
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2020/02/f34d7fcec7626144b08868be30aa3139-scaled.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200211
DTEND;VALUE=DATE:20200213
DTSTAMP:20200209T193131Z
CREATED:20200209T192624Z
LAST-MODIFIED:20200209T193131Z
UID:39221-1581379200-1581551999@globalbiodefense.com
SUMMARY:WHO Global Research and Innovation Forum: 2019-nCoV Emergency
DESCRIPTION:The World Health Organization will host a Global research and innovation forum 11-12 February in Geneva to mobilize international action in response to the novel coronavirus (2019-nCoV) emergency. \nThe event is organized in collaboration with the Global Research Collaboration for Infectious Disease Preparedness (GLOPID-R)\, and brings together key players including leading scientists as well as public health agencies\, ministries of health and research funders pursuing 2019-nCoV critical research and the development of vaccines\, therapeutics and diagnostics\, among other innovations. \nThe WHO R&D Blueprint is a global strategy and preparedness plan that allows the rapid activation of\nR&D activities during epidemics. Its aim is to fast-track the availability of effective tests\, vaccines and\nmedicines that can be used to save lives and avert large scale crisis. \nThe global imperative for research is to maintain a high-level discussion platform which enables\nconsensus on strategic directions\, nurtures scientific collaborations and\, supports optimal and rapid\nresearch to address crucial gaps\, without duplication of efforts. \nUnderstanding the disease\, its reservoirs\, its transmission\, its clinical severity and developing effective\ncounter measures is critical for the control of the outbreak\, the reduction of related mortality and\nminimization of economic impact. \nPurpose\nTo enable identification of key knowledge gaps\, and research priorities and thereby accelerate the\ngeneration of critical scientific information and the most needed medical products to contribute to\nthe control the 2019-nCoV emergency. \nExpected outcome\nA research roadmap with clearly defined priorities and governance framework addressing each of\nseveral thematic areas will be considered at the meeting\, namely: virus\, diagnostics; natural history\nand transmission; clinical; therapeutics; vaccines; ethics; regulatory science; animal health;\ndata/samples analysis and sharing and; social sciences. \nAttendees\nThe participants will include diverse multi-disciplinary teams:\n• Member States representatives from countries with cases\n• Representatives from the scientific community and public health agencies\n• Regulatory experts\n• Bioethicists with expertise in emergencies\n• Major funders of research\nWHO is delighted to welcome y
URL:https://globalbiodefense.com/event/who-global-research-and-innovation-forum-2019-ncov-emergency/
LOCATION:WHO Headquarters\, Geneva\, Switzerland
CATEGORIES:Conference
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20200219T170000
DTEND;TZID=America/Toronto:20200219T191500
DTSTAMP:20200203T162738Z
CREATED:20200203T162443Z
LAST-MODIFIED:20200203T162738Z
UID:38421-1582131600-1582139700@globalbiodefense.com
SUMMARY:2019-nCoV Update for  Health Care Providers
DESCRIPTION:Target Audience: Health care providers (including primary care physicians & nursing professionals)\n\n\n\nKey Note Speakers: \n\nDr. Gerald Evans Chair of the Division of Infectious Diseases\, Professor of Medicine\, Queens University; Attending Staff\, Kingston Health Sciences Centre\nDr. Piotr Oglaza Medical Officer of Health & CEO\, Hastings Prince Edward Public Health\nYvonne DeWit\, Epidemiologist\, Hastings Prince Edward Public Health\nMorgan Harnest\, Infection Control Lead\, PHN\, Hastings Prince Edward Public Health\n\nTopics: \n\nThe 2019 novel coronavirus\nEpidemiology\nPublic Health Response\nPersonal Protective Equipment\nWhat’s New\n\nRegistration is required. A light dinner will be provided. Please let us know if you have any dietary restrictions. \nPlease register by February 17th\, 2020.
URL:https://globalbiodefense.com/event/2019-ncov-update-for-health-care-providers/
LOCATION:Hastings Prince Edward Public Health\, 179 North Park Street\, Belleville\, ON\, K8P 4P1\, Canada
CATEGORIES:Conference
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2020/02/8f447dac25fd3022c25eafa4210f5a82.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200227T140000
DTEND;TZID=America/New_York:20200227T160000
DTSTAMP:20200220T230510Z
CREATED:20200220T225626Z
LAST-MODIFIED:20200220T230510Z
UID:40056-1582812000-1582819200@globalbiodefense.com
SUMMARY:Coronavirus Disease 2019: The U.S. and International Response
DESCRIPTION:The House Foreign Affairs Subcommittee on Asia\, the Pacific\, and Nonproliferation will hold a second subcommittee hearing on the coronavirus outbreak on 27 Feb 2020 at 2:00 Eastern. \nWitnesses will include U.S. government officials who have led the response to the virus. \nDate: Thursday\, February 27\, 2020 \nTime: 2:00 p.m. EST \nSubject: Coronavirus Disease 2019: The U.S. and International Response \nWitnesses: \n\nMr. Ian Brownlee\nPrincipal Deputy Assistant Secretary\, Bureau of Consular Affairs\, U.S. Department of State \nMr. Jonathan Fritz\nDeputy Assistant Secretary\, Bureau of East Asian and Pacific Affairs\, U.S. Department of State \nWilliam A. Walters\, Ph.D.\nExecutive Director and Managing Director for Operational Medicine\, Bureau of Medical Services\, U.S. Department of State \nRobert Redfield\, Ph.D.\nDirector\, U.S. Centers for Disease Control and Prevention
URL:https://globalbiodefense.com/event/coronavirus-disease-2019-the-u-s-and-international-response/
LOCATION:Rayburn House Office Building\, Washington\, DC\, United States
CATEGORIES:Conference,Government Hosted,Policy-Legislative
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20200228T140000
DTEND;TZID=Europe/London:20200228T170000
DTSTAMP:20200203T163127Z
CREATED:20200203T162156Z
LAST-MODIFIED:20200203T163127Z
UID:38406-1582898400-1582909200@globalbiodefense.com
SUMMARY:Faculty of Natural Sciences Research Seminar: Infectious Diseases
DESCRIPTION:Join the next FoNS Research Seminar and learn the cutting-edge research on infectious diseases taking place across the Faculty\n\n\n\nThe Faculty regularly organises events that showcase its strong research areas in order to stimulate new collaborations and discussions around a topic. The next one will be on the topic of “Infectious Diseases”. Our highlighted speakers are: \n\nProf. Ed Tate\, Professor in Chemical Biology\, Department of Chemistry\n\n\nDr Anna Barnard\, Sir Henry Dale Fellow\, Department of Chemistry\n\n\nDr Abigail Clements\, Lecturer\, Department of Life Sciences\n\n\nDr Gerald Larrouy-Maumus\, Senior Lecturer\, Department of Life Sciences\n\n\nDr Oliver Ratmann\, Lecturer in Statistics\, Department of Mathematics\n\nPhD students and postdocs will also participate at this event and their names will be announced very soon. Note there will be a drinks & canapes reception afterwards! \nFor further details about this event\, please see the event’s website.
URL:https://globalbiodefense.com/event/faculty-of-natural-sciences-research-seminar-infectious-diseases/
LOCATION:Imperial College London\, Sir Alexander Fleming Building G34 LT\, Exhibition Road\, London\, SW7 2AZ\, United Kingdom
CATEGORIES:Conference
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2020/02/89a4e54954d51d64e4de06a176f38c9a.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200229
DTEND;VALUE=DATE:20200305
DTSTAMP:20200210T165602Z
CREATED:20200210T162700Z
LAST-MODIFIED:20200210T165602Z
UID:39241-1582934400-1583366399@globalbiodefense.com
SUMMARY:16th CDC International Symposium on Biosafety
DESCRIPTION:The 16th CDC International Symposium on Biosafety – Laboratory Safety and Security for Clinical\, Public Health\, Research and Animal Care will be held 29 February – 4 March\, 2020 in Atlanta\, Georgia. \nStakeholders will learn about the soon-to-be-released 6th edition of the BMBL\, gaps in clinical and research biosafety\, risk management tools for animal facilities\, virtual reality training\, poliovirus containment\, and more. \nHighlighted sessions include: \n\nExperiences Coordinating Laboratory Policies and Procedures at CDC \nSteve Monroe\, PhD\, Centers for Disease Control and Prevention\nLaboratory Emergency Response Plans: A Team Approach\nPatrick Stockton\, MS\, RBP\, University of Georgia (Biosafety)\, Steve Harris\, University of Georgia (Emergency Preparedness)\, Captain Adam Fouche\, University of Georgia (Police)\, and Roger L. Evans\, Athens Clark County (Fire)\nLessons Learned in Risk Assessment for the Laboratory and Beyond\nRyan Ritterson\, PhD\, Gryphon Scientific\nIssues in Operation and Decontamination in Animal Research Facilities\nJason Villano\, DVM\, MSc\, MS\, DACLAM\, Johns Hopkins University \nDecontamination in the Clinical Laboratory: A Unique Environment\nSheldon Campbell\, MD\, PhD\, FCAP\, Yale School of Medicine\nUsing Risk Assessment to Identify\, Evaluate and Prioritize Facility Repairs\nJohn R. Henneman\, M.S.\, RBP/ABSA\, Biosecurity Research Institute and Miguel A. Grimaldo\, M. Eng\, University of Texas Medical Branch\n\nPlease visit the Eagleson Institute’s CDC Biosafety Symposium website for more information and to register.
URL:https://globalbiodefense.com/event/16th-cdc-international-symposium-on-biosafety/
LOCATION:Westin Perimeter North Hotel\, 7 Concourse Pkwy NE\, Atlanta\, GA\, 30328\, United States
CATEGORIES:Conference
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200302T113000
DTEND;TZID=America/New_York:20200302T120000
DTSTAMP:20200301T230419Z
CREATED:20200301T230209Z
LAST-MODIFIED:20200301T230419Z
UID:40566-1583148600-1583150400@globalbiodefense.com
SUMMARY:COVID-19 Live Webcast with Johns Hopkins Experts
DESCRIPTION:With COVID-19 now spreading via community transmission in the U.S. and the World Health Organization raising its risk assessment to “very high\,” the Johns Hopkins Bloomberg School of Public Health will host a 30-minute webcast featuring some of the best minds addressing this global health concern. \nYou’ll hear from Dr. Jennifer Nuzzo and Dr. Tara Kirk Sell of the Johns Hopkins Center for Health Security and Lauren Sauer of the Johns Hopkins Office of Critical Event Preparedness and Response. The conversation will be moderated by Dr. Joshua Sharfstein\, Vice Dean of the Johns Hopkins Bloomberg School of Public Health and former secretary of Maryland’s Department of Health. \nThey’ll discuss the findings of the Global Health Security Index referenced by President Trump last week\, what you need to know about community transmission and how to protect yourself from misinformation. They will also answer viewer questions submitted before and during the broadcast. \nSpeakers\n\nJennifer Nuzzo\, DrPH\, SM\nSenior Scholar\, Johns Hopkins Center for Health Security\nJohns Hopkins Bloomberg School of Public Health\nTara Kirk Sell\, PhD\, MA\nSenior Scholar\, Johns Hopkins Center for Health Security\nJohns Hopkins Bloomberg School of Public Health\nLauren M. Sauer\, MS\nDirector of Operations\, Johns Hopkins Office of Critical Event Preparedness and Response\nJohns Hopkins University School of Medicine\nJosh Sharfstein\, MD\nModerator\nVice Dean for Public Health Practice and Community Engagement\nJohns Hopkins Bloomberg School of Public Health\n\nA recording will be made available via on The Hub’s dedicated coronavirus page at https://hub.jhu.edu/novel-coronavirus-information/ and across Bloomberg School channels. \nThe Johns Hopkins Bloomberg School of Public Health will host additional webcasts as the coronavirus outbreak continues. Follow us on Twitter\, Facebook\, LinkedIn\, and Instagram to be notified about future broadcasts. \nThe Bloomberg School is also launching a daily “Public Health On Call” podcast with an immediate focus on the coronavirus outbreak. Subscribe via YouTube or Libsyn.
URL:https://globalbiodefense.com/event/covid-19-live-webcast-with-johns-hopkins-experts/
CATEGORIES:Conference,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200303
DTEND;VALUE=DATE:20200306
DTSTAMP:20191227T222008Z
CREATED:20191115T214342Z
LAST-MODIFIED:20191227T222008Z
UID:36020-1583193600-1583452799@globalbiodefense.com
SUMMARY:Mitigating the Impact of Blast-related Burn Injuries: From Prolonged Field Care to Rehabilitation and Resilience
DESCRIPTION:The 9th DoD State-of-the-Science Meeting on Blast Injury Research will be held March 3-5\, 2020 in Arlington\, Virginia. \nThe meeting will address epidemiology and outcomes of blast-related burn injuries; prevention and acute management of blast-related burn injuries; prolonged field care and chronic care; and transforming research. \nThis meeting is sponsored by the DoD Blast Injury Research Coordinating Office\, U.S. Army Medical Research and Development Command\, on behalf of the DoD Executive Agent for Medical Research for Prevention\, Mitigation\, and Treatment of Blast Injuries. \nThe event is presented by the RAND National Security Research Division (NSRD)\, which conducts research and analysis for all national security sponsors other than the U.S. Air Force and the Army. The division includes the National Defense Research Institute\, a federally funded research and development center whose sponsors include the Office of the Secretary of Defense\, the Joint Staff\, the Unified Combatant Commands\, the defense agencies\, and the Department of the Navy. NSRD also conducts research for the U.S. intelligence community and the ministries of defense of U.S. allies and partners. \nThis will be a working meeting. Over 100 subject matter experts from the DoD\, other Federal agencies\, academia\, industry\, and the international community are expected to participate. \nAttendance is free\, first come-first serve\, and capped at 150. There are no continuing education credits\, and participants are responsible for their own travel\, lodging\, and expenses. \nEDITOR’S UPDATE: Registration for the Ninth State-of-the-Science Meeting is now full. If you would like to be added to the waitlist\, contact the event organizers here.
URL:https://globalbiodefense.com/event/mitigating-the-impact-of-blast-related-burn-injuries-from-prolonged-field-care-to-rehabilitation-and-resilience/
LOCATION:RAND’s Pentagon City Office\, 4th Floor\, 1200 South Hayes Street\, Arlington\, VA\, 22202-5050\, United States
CATEGORIES:Conference,Government Hosted
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200312T130000
DTEND;TZID=America/New_York:20200312T143000
DTSTAMP:20200220T011222Z
CREATED:20200220T010949Z
LAST-MODIFIED:20200220T011222Z
UID:39863-1584018000-1584023400@globalbiodefense.com
SUMMARY:Center for the Study of WMD Spotlight Seminar: Coronavirus and Biosecurity
DESCRIPTION:The outbreak of the deadly coronavirus is the latest global health crisis to capture the headlines and the fears of the world. With daily updates from health officials\, there is both a surfeit of information and plenty of misinformation about the disease\, its spread\, and its origin. \nPlease join us at the Center for the Study of Weapons of Mass Destruction March Spotlight Seminar on “Coronavirus and Biosecurity.” The panel will feature experts in the fields of bioterrorism\, biosurveillance\, and infectious disease who can provide timely context for the outbreak. Panelists will assess the response to the public health emergency by the United States and China and discuss what this novel coronavirus may teach us for future natural and intentional biological events. \nIf you have any questions about the event\, please contact the CSWMD Admin staff at CSWMD-Admin@ndu.edu or call 202-433-6382. \nBiographies:\nDr. Gigi Gronvall is a Senior Scholar at the Johns Hopkins Center for Health Security and an Associate Professor in the Department of Environmental Health and Engineering at the Johns Hopkins Bloomberg School of Public Health. She is an immunologist by training. Dr. Gronvall’s work at the Center for Health Security addresses the role of scientists in health security—how they can contribute to an effective technical response against a biological weapon or a natural epidemic. She is particularly interested in developing policies that will boost the safety and security of biological science activities while allowing beneficial research to flourish. Dr. Gronvall is the author of the books Synthetic Biology: Safety\, Security\, and Promise and Preparing for Bioterrorism: The Alfred P. Sloan Foundation’s Leadership in Biosecurity. \nDr. Noreen Hynes has more than 40 years of medical and public health experience in both international and domestic settings. She is a physician trained in internal medicine\, infectious diseases\, tropical medicine\, and epidemiology. Prior to her medical education\, Dr. Hynes served as a Peace Corps Volunteer in Tunisia\, followed by serving as a Foreign Service Officer in Mali and Cote d’Ivoire\, and then received a master of public health degree from Johns Hopkins University. After earning a medical degree from the Uniformed Services University of the Health Sciences in Bethesda\, MD\, Dr. Hynes completed a residency in internal medicine and a fellowship in infectious diseases at the Massachusetts General Hospital/Harvard Medical School. As a Commissioned Officer in the U.S. Public Health Service\, Dr. Hynes’ duty stations included Atlanta (Epidemic Intelligence Service)\, Colorado\, Arkansas\, Baltimore\, and Washington D.C. Following the events of late 2001\, she served as senior advisor to the Vice President of the United States for Medicine and Public Health (Homeland Security). Prior to retirement from government service in 2007\, Dr. Hynes was the deputy assistant secretary for Public Health Emergency Preparedness and the director of the Office of Public Health Emergency Medical Countermeasures (now the Biomedical Advanced Research and Development Authority – BARDA) at the US Department of Health and Human Services. Since 1997\, Dr. Hynes has been a part-time faculty member at the Johns Hopkins University Schools of Medicine and Public Health. She directs the Geographic Medicine Center of the Division of Infectious Diseases and serves as the associate medical director of the Biocontainment Unit of the Johns Hopkins Hospital — a unit focused on the care of patients with high consequence pathogens\, such as Ebola. At the Bloomberg School of Public Health\, Dr. Hynes co-directs the infectious diseases concentration in the master of public health program and co-teaches a course focused on the science\, public health and policy aspects of chemical and biological weapons. Her research focuses on vaccine-preventable diseases\, tropical diseases\, zoonotic infections\, and high consequence pathogens. \nDr. Rohit Chitale joined DARPA as a program manager in 2019. He is an infectious disease epidemiologist with more than 20 years of experience helping national and international organizations establish and lead programs related to infectious disease prevention and eradication\, with specific expertise in the design and implementation of disease surveillance systems and the development of new disease control tools. Before coming to DARPA\, Dr. Chitale co-established the Global Disease Detection Operations Center at the U.S. Centers for Disease Control and Prevention (CDC)\, the first event-based all-hazards surveillance unit at the CDC. He also served as the CDC Country Director in the Republic of South Sudan. In a prior role at the U.S. Department of Defense (DoD)\, he established and led the Division of Integrated Biosurveillance within the Armed Forces Health Surveillance Center to address capability gaps in DoD biosurveillance and global health security operations. In that role\, he led efforts to integrate syndromic\, case-based\, and event-based disease surveillance systems across civilian\, military\, and veteran populations to decrease the time to disease detection\, diagnosis\, and treatment. While at DoD\, he helped write the Global Health Security Agenda legislation. Previously\, at the Johns Hopkins Bloomberg School of Public Health\, Dr. Chitale co-created The MENTOR Initiative — a public-private partnership designed to test and evaluate (pre-clinical\, Phase I\, II\, and III trials) new vector-borne disease control technologies.
URL:https://globalbiodefense.com/event/center-for-the-study-of-wmd-spotlight-seminar-coronavirus-and-biosecurity/
LOCATION:National Defense University\, 300 5th Avenue SW\, Washington\, DC\, 20319\, United States
CATEGORIES:Conference
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200316
DTEND;VALUE=DATE:20200318
DTSTAMP:20200223T181226Z
CREATED:20200223T173102Z
LAST-MODIFIED:20200223T181226Z
UID:40151-1584316800-1584489599@globalbiodefense.com
SUMMARY:IABS-CEPI Vaccine Technology Platforms Meeting
DESCRIPTION:A cross-learning symposium on vaccine licensure based on technology platforms\, the IABS-CEPI-ZAPI Technology Platforms Meeting\, will take place 16-17 March 2020 in Brussels\, Belgium. \nThe scientific committee for this workshop is co-Chaired by: \n\nDaniel Brasseur\, former CHMP-PDCO-VWP chair at EMA; CEPI consultant\nMurray Lumpkin\, former Deputy Director\, FDA; Bill & Melinda Gates Foundation\n\nHighlighted topics of interest on the agenda include: \n\nWHO regulatory preparedness activities to facilitate access to emergency vaccines\nHuman influenza vaccine successes and failures\nLessons for emergency preparedness leaned from Ebola vaccine development and licensure\nRegulatory approach to vaccine tech platforms: FDA perspective\, EU approach\, AVAREF\, Asian regulators\nAdvanced human vaccines in the pipeline (viral vectors\, VSV-Measles-ChAd…) and RNA\, DNA technologies\nTo what extent can clinical trials be pre-arranged?\nDetermining what is platform generic vs. platform specific in manufacturing and quality control\nChallenges to prove vaccine efficacy for outbreak vaccines and mitigating risk\nStreamlining regulatory acceptance from ‘tried and true’ vaccine platforms\n\nIn addition\, CEPI will review its current portfolio and examples of vaccine candidates based on technology platforms. \nMembers of the Scientific Committee include: \n\nDr. Barney Graham\, NIH\, Deputy Director and Chief\, Viral Pathogenesis Laboratory\nDr. Mélanie Saville\, Director\, Vaccine Development\, CEPI\nProf. Dr. Johan Neyts\, Rega Institute Louvain\, Belgium\, specialist of DNA vaccine PLLAV\nDr. Marion Gruber\, FDA\, Director\, Office of Vaccine Research and Review – CBER\nDr. Ivo Classen\, EMA\, Head of Veterinary Medicines Division\nDr. Marco Cavaleri\, EMA\, Head of Anti-infectives and Vaccines\nProf Dr. Jeffery Almond\, Oxford University; Chairman of the Board\, Osivax\nDr. Jean-Christophe Audonnet\, Senior Director\, Vaccines R&D; ZAPI Project Coordinator;\nBoehringer Ingelheim Animal Health\nDr. Emmanuel Hanon\, Senior Vice President\, Head of R&D\, GSK Vaccines\nDr Ajoy Chakrabarti\, Bill & Melinda Gates Foundation Vaccine Development\nDr Steve Black\, The Brighton Collaboration\, Task Force for Global Health\n\nRegister now for the IABS-CEPI Technology Platforms Meeting
URL:https://globalbiodefense.com/event/iabs-cepi-vaccine-technology-platforms-meeting/
CATEGORIES:Conference,Industry Day
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200318T100000
DTEND;TZID=America/New_York:20200318T154500
DTSTAMP:20200210T161026Z
CREATED:20200210T160543Z
LAST-MODIFIED:20200210T161026Z
UID:39238-1584525600-1584546300@globalbiodefense.com
SUMMARY:Next Evolution: Overhauling Key Elements of Biodefense
DESCRIPTION:The Bipartisan Commission on Biodefense will convene a meeting entitled ‘Next Evolution: Overhauling Key Elements of Biodefense‘ on March 18\, 2020 in Washington D.C. and made available by webcast. \nThis meeting aims to inform the assessment of biodefense programs with structural challenges that impede the government’s ability to safeguard the Nation. \nTopics to be discussed at this meeting include the: \n\nSelect Agent Program\nBioWatch Program\nHospital Preparedness Program\n\nSpeakers will share their perspectives\, experiences\, challenges\, and recommended solutions with regard to federal biodetection\, pathogen security\, and hospital preparedness programs. \nRegistration is required and attendance is free. \nWednesday\, March 18\, 2020 \n10:00 AM – 3:45 PM \nHudson Institute \n1201 Pennsylvania Avenue\, NW\, 4th floor \nWashington\, DC 20004 \nSee map \n  \n 
URL:https://globalbiodefense.com/event/next-evolution-overhauling-key-elements-of-biodefense/
LOCATION:Hudson Institute\, 1201 Pennsylvania Avenue Northwest\, #400\, Washington\, DC\, 20004\, United States
CATEGORIES:Conference,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200324
DTEND;VALUE=DATE:20200326
DTSTAMP:20200323T210103Z
CREATED:20200319T205750Z
LAST-MODIFIED:20200323T210103Z
UID:42054-1585008000-1585180799@globalbiodefense.com
SUMMARY:BIO Coronavirus Collaboration Initiative Virtual Summit
DESCRIPTION:The Biotechnology Innovation Organization (BIO) is hosting a virtual summit to help companies working on COVID-19 treatments\, diagnostics and vaccines to come together to discuss challenges and opportunities with government officials and other stakeholders. \nThe two-day summit will take place on Tuesday\, March 24 and Wednesday\, March 25\, and will be led by BIO President and CEO Jim Greenwood and Dr. George Scangos\, President and CEO of Vir Biotechnology. BIO Board Chairman Dr. Jeremy Levin\, CEO of Ovid Therapeutics\, appointed Dr. Scangos to oversee the BIO Coronavirus Collaboration Initiative\, which is intended to help connect innovators with partners across both the industry and inside the federal government to combat the coronavirus. \nThe summit will include leaders from biotech and pharmaceutical companies\, global academic experts in virology and immunology\, and non-governmental organizations. Those invited to participate include Ambassador Deborah Birx\, Dr. Robert Kadlec\, and other senior leaders from key government offices\, including the U.S. Department of Defense\, U.S. Department of Health & Human Services\, the Centers for Disease Control and Prevention\, National Institutes of Health\, and the Food and Drug Administration. Information regarding confirmed guests will be provided at a later date. \nAs an international trade association representing more than 700 biotechnology companies\, BIO is playing a unique role in organizing and coordinating the activities of many of its companies. More than 45 member companies are working to address coronavirus and more than 20 have products in various stages of development. \n“Close collaboration between America’s biopharmaceutical companies and the U.S. government is leading the global race to develop vaccines and cures to protect society from the coronavirus\,” said BIO President and CEO Jim Greenwood. “Our researchers and scientists are at the forefront of this important effort\, and they will answer the challenge just as they always have. This virtual summit is a critical step to helping industry leaders\, government officials\, and other vital partners collaborate and ultimately accelerate the development of new medicines to overcome this global threat. BIO is uniquely positioned to help drive this collaboration\, and this is one step in our broader efforts to combat the coronavirus.” \n“Across the biopharmaceutical industry\, men and women are working tirelessly under difficult circumstances to combat the coronavirus\,” said Dr. Scangos.“We are witnessing the true motivation of people in the industry – to do everything we can to bring medicines to people who need them. I am gratified to see people working incredibly hard to bring forward treatments for Covid-19 as quickly as humanly possible. I am pleased to help lead this virtual summit\, which will help facilitate the collaboration and public-private partnerships necessary to treat the sick and prevent further spread of the coronavirus.” \nThe virtual summit will feature presentations and discussions on the latest epidemiologic developments related to the coronavirus\, response work that is underway\, and where critical gaps exist in current R&D and response efforts. The meeting will focus on three key areas of the response: diagnosing the virus\, treating those with the virus\, and preventative measures to contain further transmission of the virus.
URL:https://globalbiodefense.com/event/bio-coronavirus-collaboration-initiative-virtual-summit/
LOCATION:Webinar
CATEGORIES:Conference,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200325T150000
DTEND;TZID=America/New_York:20200325T163000
DTSTAMP:20200325T061035Z
CREATED:20200324T060239Z
LAST-MODIFIED:20200325T061035Z
UID:42230-1585148400-1585153800@globalbiodefense.com
SUMMARY:Responding to COVID-19 Webinar: The Science of Social Distancing
DESCRIPTION:Brought to you by the American Public Health Association and the National Academy of Medicine\, The Science of Social Distancing webinar series will explore the state of the science surrounding the current outbreak of COVID-19 in the United States and globally\, with a focus on the emerging evidence on how to best mitigate its impact. Hear from trusted experts in such fields as public health\, infectious disease\, risk communication\, and crisis standards of care. \n\n\nBrought to you by the American Public Health Association and the National Academy of Medicine\, this webinar series will explore the state of the science surrounding the current outbreak of COVID-19 in the United States and globally\, with a focus on the emerging evidence on how to best mitigate its impact. Hear from trusted experts in such fields as public health\, infectious disease\, risk communication\, and crisis standards of care. \nThe webinar will feature a panel of expert speakers\, including: \n\nNancy Messonnier\, MD — Director\, National Center for Immunization and Respiratory Diseases\, Centers for Disease Control and Prevention\nMarc Lipsitch\, DPhil — Director\, Center for Communicable Disease Dynamics\, Harvard T. H. Chan School of Public Health\nMitch Stripling — National Director\, Emergency Preparedness and Response\, Planned Parenthood and former assistant commissioner of Agency Preparedness and Response for New York City\nHoward Markel\, MD\, PhD — George E. Wantz Distinguished Professor of the History of Medicine and Director of the Center for the History of Medicine\, University of Michigan\n\nThe webinar series will draw from and complement existing advisory activities underway at APHA and the National Academies\, including the Standing Committee on Emerging Infectious Diseases and 21st Century Health Threats\, which was convened for the purpose of advising the White House and federal agencies on the U.S. response to COVID-19. \nThe series will rapidly and regularly provide trustworthy scientific analysis of the latest COVID-19 developments for the benefit of policymakers\, public health and health care officials\, and the general public. The series will explore the scientific basis for guidance issued by government\, health and public health organizations\, and industry\, as well as answer questions that are top of mind for its audiences.
URL:https://globalbiodefense.com/event/responding-to-covid-19-webinar-the-science-of-social-distancing/
LOCATION:Virtual-Webcast
CATEGORIES:Conference,Webinar-Webcast
END:VEVENT
END:VCALENDAR